New COVID-19 vaccine study for healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests a new COVID-19 vaccine (called BMI2012) in healthy adults. It aims to see if the vaccine is safe and triggers a good immune response against new variants of the virus. If you qualify, you'd receive the vaccine and be monitored over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 55 years old.
- It must be at least 3 months since your last COVID-19 vaccine or confirmed infection.
- Your BMI (a height-to-weight ratio) must be between 18 and 30.
- You must be generally healthy, without serious heart, lung, autoimmune, or other conditions.
- If you or your partner can have children, you must use highly effective birth control during the study.
- You can't have had COVID-19 recently or be in close contact with someone who has it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
This study tests a new nasal spray COVID-19 vaccine to see how it compares to an mRNA booster shot. It is for healthy adults who have already had at least 3 doses of an mRNA COVID-19 vaccine (or 2 doses plus a confirmed COVID infection) and are looking for a needle-free booster option.
This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Prevention of COVID-19 Variant (Omicron JN.1) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.